SLC7A11 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma, a CSC marker CD44 variant was found to directly bind to the cystine/glutamate antiporter xCT, thereby increasing GSH synthesis, which is involved in therapy resistance (50).